An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures

Trial Profile

An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jan 2016

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 11 May 2008 End date, status and patient no's updated from nct (7-5-08) via dms.
    • 11 May 2008 Status changed from in progress to completed.
    • 07 Aug 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top